← Eichor
Study identifier: NCT06192914 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

EPAP, Interviewstudy

Condition: Food Allergy · Food Allergy Peanut · Allergy  ·  Sponsor: Charite University, Berlin, Germany

PhaseN/A
Planned participants322
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn about repetitive anaphylactic reactions in food allergic patients and to compare the frequency of repetitive reactions between different elicitors in food allergic patients. The main question it aims to answer are: • Is there an elicitor specific difference in the occurrence of anaphylactic reactions once the elicitor has been identified and the patient received counselling about its avoidance? Participants will answer questionnaires via a link they will receive via e-mail at baseline and 3, 6, 12 and 24 months after inclusion in the study.

This description comes directly from the study's public registry record.

Talk to the study team

Margitta Worm, MD  ·  +49 30 450 518 105  ·  sekreteriat-worm@charite.de

Sabine Dölle-Bierke, PhD  ·  +49 30 450 518 367  ·  sabine.doelle@charite.de

Always discuss trial participation with your own doctor first.

Locations (1)

Charité - Universitätsmedizin BerlinBerlin, State of Berlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06192914